VBI Vaccines Awarded $56M from Strategic Innovation Fund

Ontario Industry Updates
Written By Guest User
VBI_Logo_New-Blue-1500.jpg

VBI Vaccines has been awarded up to $56 million from the federal Strategic Innovation Fund to ramp up development and testing of its experimental vaccine. The company is hoping this funding injection from the federal government will be just the boost it needs to develop a homegrown vaccine against COVID-19 and other deadly coronaviruses.

Guest User
Previous

7D Surgical Receives HSA Approval in Singapore and Achieves First Unit Sales in Southeast Asia

Next

Curiato Presents at International Medical Conference